TrianglePUBLICATIONS · 10520026
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 1999 Oct
- First author
- Wheatley K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wheatley K
- type
- Author
- name
- Burnett AK
- type
- Author
- name
- Goldstone AH
- type
- Author
- name
- Gray RG
- type
- Author
- name
- Hann IM
- type
- Author
- name
- Harrison CJ
- type
- Author
- name
- Rees JK
- type
- Author
- name
- Stevens RF
- type
- Author
- name
- Walker H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wheatley K
- type
- Author
- name
- Burnett AK
- type
- Author
- name
- Goldstone AH
- type
- Author
- name
- Gray RG
- type
- Author
- name
- Hann IM
- type
- Author
- name
- Harrison CJ
- type
- Author
- name
- Rees JK
- type
- Author
- name
- Stevens RF
- type
- Author
- name
- Walker H
- type
- Author
- bibliography ids
- nci-bib-28b94ee73340dc3929df7c39
- book metadata
- content sha256
- 27291a41ac9160fe879c675c5d809ce9dd455cb83482cc04f273fa3974fae625
- document type
- citation
- dois
- 10.1046/j.1365-2141.1999.01684.x
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10520026
- immutable id
- pubmed:10520026@27291a41ac9160fe879c675c5d809ce9dd455cb83482cc04f273fa3974fae625
- journal
- abbreviation
- Br J Haematol
- issn electronic
- Source null
- issn print
- 0007-1048
- issue
- 1
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 69-79
- volume
- 107
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 10520026
- provenance
- batch id
- 40703d4bdd5a70d2c67a
- provider
- NCBI PubMed ESummary
- record sha256
- 100a49df5d80ab3c22066dcf179b039b9bb0b64984c422444a4598aa59da8588
- response sha256
- a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
- retrieved at
- 2026-09-09T23:45:35.800055+00:00
- publication date
- display
- 1999 Oct
- precision
- month
- year
- 1999
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.
Preserved source evidence · Not medical advice